Work

Eficacia y tolerabilidad del policosanol en pacientes con hipercolesterolemia tipo II

Year: 1999
Type: article
Study design: Clinical Trial
Abstract: The present open study investigates the efficacy and tolerability of policosanol administered at 5 or 10 mg/d to patients with type II hypercholesterolemia. One hundred patients (44 men, 56 women) following a step one cholesterol-lowering dietwere included in the trial and advised to take the tablets once-a-daywith the evening meal for 6 months . The study population showed a high frequency of hypertension (58 %), low HDL-C values (< 35 mg/dL) (20 17o), diabetes (12 %), coronary diseases (10 %) and obesity (8 %) . A 34 % of the patients showed two or more coronary risk factors in addition to hypercholesterolemia, which indicates the high global risk of the study patients . Eighty one patients started therapy with 5 mg and 19 cases with 10 mg . Only ten of 81 cases initially treated with 5 mg/d the doses value adjusted to 10 mg/d . After two months of therapy, policosanol significantly lowered total cholesterol (12 .8 %), LDL-C (16 .9 %), triglycerides (10 .7 %), and cholesterol to HDL-C (20.4 %), LDL to HDL-C ratios (23 .5 %)and raised HDL-C levels by 12 % . These changes were not only sustained, but increased, over the 6 months follow up . Thus, after 6 months of policosanol therapy total cholesterol lowered by 21 .8 %, LDL-C by 28.6 %, triglycerides (21.6 %), total cholesterol to HDL-C ratio by 33 .8 % and LDL-C to HDL-C ratio by 38.7 % compared with baseline. Three patients (3 %) discontinued the study because of moderate gastrointestinal adverse experiences . These results show that policosanol is effective and well tolerated administered for 6 months to patients with type II hypercholesterolemia, thus corroborating results obtained in previous randomized double-blind studies.
Language: Spanish
Field: Medicine
Open Access status: diamond
OpenAlex ID: W1513834211
FWCI:
Cites:
Cited by: 1
Related to: 10